vimarsana.com
Home
Live Updates
FDA Encourages The Use Of Decentralized Clinical Trials In N
FDA Encourages The Use Of Decentralized Clinical Trials In N
FDA Encourages The Use Of Decentralized Clinical Trials In New Draft Guidance - Healthcare
On May 2, 2023, the U.S. Food and Drug Administration (FDA) released Draft Guidance regarding the implementation of Decentralized Clinical Trials (DCTs) for drugs, biological products, and devices.
Related Keywords
Robertm Califf ,
,
Drug Administration ,
Digital Health Technologies For Remote Data ,
Draft Guidance ,
Decentralized Clinical Trials ,
Decentralized Clinical ,
Digital Health Technologies ,
Remote Data ,
Clinical Investigations ,
Mondaq ,
Fda Encourages The Use Of Decentralized Clinical Trials In New Draft Guidance ,
Food ,
Drugs ,
Healthcare ,
Life Sciences ,
Food And Drugs Law ,
Transport ,
Marine Shipping ,